blog | Nasdaq

IPOs, Nasdaq, 2026, Minimed

MiniMed Debuts on Nasdaq as IPO Prophet Signals Align With Weak First-Day Trading

$Picture of {{ content.blog_author.display_name }}$ Eric Friedman

Mar 6, 2026 5:14:41 PM

MiniMed Group, Inc. (MMED), a diabetes technology company with approximately $2.3 billion in fiscal ...

IPOs, Nasdaq, 2026, FinTech, PayPay

$Picture of {{ content.blog_author.display_name }}$ Eric Friedman

Mar 3, 2026 5:31:43 PM

IPOs, Nasdaq, Medline, 2026, Minimed

$Picture of {{ content.blog_author.display_name }}$ Eric Friedman

Feb 24, 2026 1:04:33 PM

Nasdaq, 2026, Generate Biomedicines

$Picture of {{ content.blog_author.display_name }}$ Eric Friedman

Feb 23, 2026 4:06:42 PM

IPOs, Nasdaq, 2026, Arko Petroleum

$Picture of {{ content.blog_author.display_name }}$ Dave Berlin

Feb 12, 2026 4:21:31 PM

ARKO Petroleum finished the session with a neutral close but bearish intraday signal context, highli...

IPOs, Nasdaq, 2026, Arko Petroleum

$Picture of {{ content.blog_author.display_name }}$ Eric Friedman

Feb 5, 2026 4:22:10 PM

IPOs, Nasdaq, 2026, Clear Street Group

$Picture of {{ content.blog_author.display_name }}$ Eric Friedman

Feb 5, 2026 3:03:47 PM

IPOs, Nasdaq, 2026, Solv Energy, Solar

$Picture of {{ content.blog_author.display_name }}$ Eric Friedman

Feb 3, 2026 5:51:22 PM

IPOs, Nasdaq, 2026, SpyGlass Pharma

$Picture of {{ content.blog_author.display_name }}$ Eric Friedman

Jan 30, 2026 4:51:35 PM

IPOs, Nasdaq, 2026, AgomAb

$Picture of {{ content.blog_author.display_name }}$ Eric Friedman

Jan 30, 2026 2:56:35 PM

AgomAb Therapeutics NV has set terms for its initial public offering, positioning the fibrosis-focus...

First Prev 1 2 3 4 Next Last